Global Health Updates: Berkshire's New Moves and Bioethanol Industry Woes

The summary covers recent significant developments in health news including Warren Buffett's Berkshire Hathaway's investment in UnitedHealth Group and the struggles of the UK's bioethanol industry due to a trade deal. It also highlights the FTC's investigation into Hims & Hers and Apple’s new health feature.

This week's health news is dominated by Warren Buffett's Berkshire Hathaway, which revealed a substantial investment in UnitedHealth Group. The move comes amid increasing scrutiny of the health insurer. Berkshire's stake, worth approximately $1.57 billion, has created buzz in the healthcare sector.

Meanwhile, Britain's bioethanol industry faces a crisis as the government refuses financial aid following a detrimental trade deal with the US under President Trump. The sector's potential collapse poses a political challenge for Prime Minister Keir Starmer.

The U.S. Federal Trade Commission is investigating telehealth company Hims & Hers over its advertising strategies, which has led to a dip in its stock value. Additional news includes Apple's latest health innovation—a blood oxygen measurement feature for its smartwatches—underlining growing interest in consumer health tech.

(With inputs from agencies.)